Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
BMC Cancer
|
February 22, 2023
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Alessia Visconti, Niccolò Rossi, Helena Deriš, et al.
Nature Medicine
|
March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Cancer Research Communications
|
October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
BMC Cancer
|
February 22, 2023
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Alessia Visconti, Niccolò Rossi, Helena Deriš, et al.
Nature Medicine
|
March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Cancer Research Communications
|
October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Page
of 2